Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CpG oligonucleotides as immune adjuvants

A M Krieg1

  • 1University of Iowa, Department of Internal Medicine, Iowa City 52242, USA.

Ernst Schering Research Foundation Workshop
|August 16, 2000
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunostimulatory CpG motifs and DNA vaccines.

Methods in molecular medicine·2011
Same author

DNA-based immune enhancers.

Current opinion in drug discovery & development·2009
Same author

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.

Oncogene·2008
Same author

The CpG motif: implications for clinical immunology.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.

Current topics in microbiology and immunology·2006
Same author

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.

Journal of clinical immunology·2004